SARS-CoV-2 Spike Rekombinanter Antikörper
SARS-CoV-2 Spike Rekombinant Antikörper für ELISA
Wirt / Isotyp
Mensch / IgG1
Getestete Reaktivität
Virus
Anwendung
, ELISA
Konjugation
Unkonjugiert
CloneNo.
AM032414
Kat-Nr. : 91359-PTG
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in ELISA | SARS-CoV-2-Spike-RBD-Protein |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Sample dependent. To be determined by the end user. |
Note: Proteintech is partnering with Active Motif to bring these cutting-edge, patient derived antibodies to our customers during this important time for COVID-19 research.
Produktinformation
91359-PTG bindet in , ELISA SARS-CoV-2 Spike und zeigt Reaktivität mit Virus
Getestete Reaktivität | Virus |
Wirt / Isotyp | Mensch / IgG1 |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | Virus |
Vollständiger Name | SARS-CoV-2 Spike Protein |
Berechnetes Molekulargewicht | 141 kDa |
GenBank-Zugangsnummer | NC_045512 |
Gene symbol | COVID-19 S Protein |
Gene ID (NCBI) | 43740568 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Chromatographie |
Lagerungspuffer | 140 mM Hepes, pH 7,5, 70 mM NaCl, 32 mM NaOAc, 0,035% Natriumazid und 30% Glyzerin. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
COVID-19, which is short for coronavirus disease 2019, is the official name of the respiratory disease caused by infection with the novel coronavirus SARS-CoV-2. The virus that causes COVID-19 was named SARS-CoV-2 because it is a coronavirus genetically similar to, yet distinct from, the virus that caused the severe acute respiratory syndrome (SARS) outbreak in 2003. Studying the details of how this virus replicates and causes the disease will allow scientists and physicians to more rapidly develop fast and accurate methods of detection as well as to deploy therapeutic and vaccine strategies. This antibody was derived from COVID-19 patients who have cleared the virus. Patient serum IgG was sequenced and expressed as full-length IgG1 with human immunoglobulin heavy and light chains in mammalian 293 cells.